Co-crystal structure of monoclonal antibody 5C8 and CD154, and use thereof in drug design

Details for Australian Patent Application No. 2001288675 (hide)

International Classifications

Event Publications

1 May 2003 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Mar 2003

28 April 2005 Change of Name(s) of Applicant(s), Section 104

Biogen, Inc. The name of the applicant has been changed to Biogen Idec MA Inc.

30 August 2007 Application Accepted

Published as AU-B-2001288675

3 January 2008 Standard Patent Sealed

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.